191 related articles for article (PubMed ID: 31069142)
21. Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer.
Isaacs J; Anders C; McArthur H; Force J
Curr Treat Options Oncol; 2021 Mar; 22(5):38. PubMed ID: 33743085
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068
[TBL] [Abstract][Full Text] [Related]
23. Wnt1-inducible signaling protein 1 regulates laryngeal squamous cell carcinoma glycolysis and chemoresistance via the YAP1/TEAD1/GLUT1 pathway.
Wang L; Sun J; Gao P; Su K; Wu H; Li J; Lou W
J Cell Physiol; 2019 Sep; 234(9):15941-15950. PubMed ID: 30805937
[TBL] [Abstract][Full Text] [Related]
24. High expression of WISP1 in colon cancer is associated with apoptosis, invasion and poor prognosis.
Wu J; Long Z; Cai H; Du C; Liu X; Yu S; Wang Y
Oncotarget; 2016 Aug; 7(31):49834-49847. PubMed ID: 27409174
[TBL] [Abstract][Full Text] [Related]
25. WISP1 Is Involved in the Pathogenesis of Kashin-Beck Disease via the Autophagy Pathway.
Li P; Cheng B; Yao Y; Yu W; Liu L; Cheng S; Zhang L; Ma M; Qi X; Liang C; Chu X; Ye J; Sun S; Jia Y; Guo X; Wen Y; Zhang F
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003226
[TBL] [Abstract][Full Text] [Related]
26. CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer.
Gurbuz I; Chiquet-Ehrismann R
Int J Biochem Cell Biol; 2015 May; 62():142-6. PubMed ID: 25794425
[TBL] [Abstract][Full Text] [Related]
27. A novel epithelial-mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer.
Jin Y; Qiu Y; Li Y; Jiang Z; Hu S; Dai H
Medicine (Baltimore); 2023 Jun; 102(26):e34126. PubMed ID: 37390286
[TBL] [Abstract][Full Text] [Related]
28. Identification of WISP1 as a novel oncogene in glioblastoma.
Jing D; Zhang Q; Yu H; Zhao Y; Shen L
Int J Oncol; 2017 Oct; 51(4):1261-1270. PubMed ID: 28902353
[TBL] [Abstract][Full Text] [Related]
29. WISP1 mediates lung injury following hepatic ischemia reperfusion dependent on TLR4 in mice.
Tong Y; Yu Z; Zhang R; Ding X; Chen Z; Li Q
BMC Pulm Med; 2018 Dec; 18(1):189. PubMed ID: 30522479
[TBL] [Abstract][Full Text] [Related]
30. Pan-Cancer Analysis Shows Enrichment of Macrophages, Overexpression of Checkpoint Molecules, Inhibitory Cytokines, and Immune Exhaustion Signatures in EMT-High Tumors.
Tiwari JK; Negi S; Kashyap M; Nizamuddin S; Singh A; Khattri A
Front Oncol; 2021; 11():793881. PubMed ID: 35096592
[TBL] [Abstract][Full Text] [Related]
31. Correlation between the immune checkpoints and EMT genes proposes potential prognostic and therapeutic targets in ESCC.
Mahmoudian RA; Mozhgani S; Abbaszadegan MR; Mokhlessi L; Montazer M; Gholamin M
J Mol Histol; 2021 Jun; 52(3):597-609. PubMed ID: 33884540
[TBL] [Abstract][Full Text] [Related]
32. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma.
Chen X; Wang K; Jiang S; Sun H; Che X; Zhang M; He J; Wen Y; Liao M; Li X; Zhou X; Song J; Ren X; Yi W; Yang J; Chen X; Yin M; Cheng Y
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35347072
[TBL] [Abstract][Full Text] [Related]
33. A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma.
Luo X; Wang Q; Tang H; Chen Y; Li X; Chen J; Zhang X; Li Y; Sun J; Han S
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676646
[No Abstract] [Full Text] [Related]
34. WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone.
Ono M; Inkson CA; Sonn R; Kilts TM; de Castro LF; Maeda A; Fisher LW; Robey PG; Berendsen AD; Li L; McCartney-Francis N; Brown AC; Crawford NP; Molinolo A; Jain A; Fedarko NS; Young MF
PLoS One; 2013; 8(8):e71709. PubMed ID: 23977121
[TBL] [Abstract][Full Text] [Related]
35. Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC.
Della Corte CM; Ciaramella V; Ramkumar K; Vicidomini G; Fiorelli A; Nardone V; Cappabianca S; Cozzolino I; Zito Marino F; Di Guida G; Wang Q; Cardnell R; Gay CM; Ciardiello D; Martinelli E; Troiani T; Martini G; Napolitano S; Wang J; Byers LA; Ciardiello F; Morgillo F
J Transl Med; 2022 Nov; 20(1):541. PubMed ID: 36419183
[TBL] [Abstract][Full Text] [Related]
36. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
Gao B; Wang Y; Lu S
Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
[TBL] [Abstract][Full Text] [Related]
37. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract][Full Text] [Related]
38. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
39. Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
Fröhlich A; Sirokay J; Fietz S; Vogt TJ; Dietrich J; Zarbl R; Florin M; Kuster P; Saavedra G; Valladolid SR; Hoffmann F; Flatz L; Ring SS; Golletz C; Pietsch T; Strieth S; Brossart P; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
EBioMedicine; 2020 Sep; 59():102962. PubMed ID: 32861198
[TBL] [Abstract][Full Text] [Related]
40. High expression of WISP1 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.
Wang QY; Feng YJ; Ji R
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10445-10451. PubMed ID: 33155200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
